Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Sophia Genetics sees FY21 revenue over $39M, consensus $37.31M  07:18
09/09/21
09/09
07:18
09/09/21
07:18
SOPH

Sophia Genetics

$17.74 /

+0.3 (+1.72%)

 
ShowHide Related Items >><<
SOPH Sophia Genetics
$17.74 /

+0.3 (+1.72%)

SOPH Sophia Genetics
$17.74 /

+0.3 (+1.72%)

08/17/21 Cowen
Cowen starts 'emerging leader' Sophia Genetics with Outperform
08/17/21
Fly Intel: Top five analyst initiations
08/17/21 JPMorgan
Sophia Genetics initiated with Overweight, $23 target at JPMorgan
08/17/21 Morgan Stanley
Morgan Stanley starts Sophia Genetics at Overweight with $24 price target
SOPH Sophia Genetics
$17.74 /

+0.3 (+1.72%)

  • 23
    Jul
SOPH Sophia Genetics
$17.74 /

+0.3 (+1.72%)

Earnings
Sophia Genetics reports Q2 EPS (31c), consensus (39c) » 07:17
09/09/21
09/09
07:17
09/09/21
07:17
SOPH

Sophia Genetics

$17.74 /

+0.3 (+1.72%)

Reports Q2 revenue…

Reports Q2 revenue $10.2M, consensus $8.6M. "We had solid execution across our business during Q2, growing top line revenue more than 70% over the prior year period," said CEO Jurgi Camblong. "I am encouraged by our growing customer base as well as the increasing enthusiasm around for the impacts data driven medicine can have on patient outcomes. Overall, I am so proud of what we have achieved at SOPHiA and even more excited for what lies ahead. We are committed to unlocking data siloes, leveraging AI to generate actionable insights from data, and helping healthcare professionals work together as a community and deploy their collective expertise for the benefit of patients around the world."

ShowHide Related Items >><<
SOPH Sophia Genetics
$17.74 /

+0.3 (+1.72%)

SOPH Sophia Genetics
$17.74 /

+0.3 (+1.72%)

08/17/21 Cowen
Cowen starts 'emerging leader' Sophia Genetics with Outperform
08/17/21
Fly Intel: Top five analyst initiations
08/17/21 JPMorgan
Sophia Genetics initiated with Overweight, $23 target at JPMorgan
08/17/21 Morgan Stanley
Morgan Stanley starts Sophia Genetics at Overweight with $24 price target
  • 23
    Jul
SOPH Sophia Genetics
$17.74 /

+0.3 (+1.72%)

Hot Stocks
Sophia Genetics and Dasa expand partnership to offer HRD analytics solution » 09:02
08/24/21
08/24
09:02
08/24/21
09:02
SOPH

Sophia Genetics

$18.10 /

+0.135 (+0.75%)

Dasa, the largest…

Dasa, the largest integrated healthcare network in Brazil, expanded its partnership with SOPHiA GENETICS to offer the first decentralized HRD, or Homologous recombination deficiency, analytics solution in Latin America. HRD is a complex biomarker, important for PARP inhibitors, that helps identify whether cancer patients may respond better to specific treatments, and its use could ultimately lead to personalized therapies that benefit the individual patient. Renowned in Brazil and abroad, Dasa serves more than 20M patients per year

ShowHide Related Items >><<
SOPH Sophia Genetics
$18.10 /

+0.135 (+0.75%)

08/17/21 Cowen
Cowen starts 'emerging leader' Sophia Genetics with Outperform
08/17/21
Fly Intel: Top five analyst initiations
08/17/21 JPMorgan
Sophia Genetics initiated with Overweight, $23 target at JPMorgan
08/17/21 Morgan Stanley
Morgan Stanley starts Sophia Genetics at Overweight with $24 price target
  • 23
    Jul
SOPH Sophia Genetics
$18.10 /

+0.135 (+0.75%)

Over a month ago
Initiation
Cowen starts 'emerging leader' Sophia Genetics with Outperform » 10:31
08/17/21
08/17
10:31
08/17/21
10:31
SOPH

Sophia Genetics

$18.11 /

+0.11 (+0.61%)

Cowen analyst Doug…

Cowen analyst Doug Schenkel initiated coverage of Sophia Genetics with an Outperform rating and no price target. Sophia is an "emerging leader" in the decentralization of comprehensive genetic testing and the company seeks to expand into adjacencies, such as proteomics, Schenkel tells investors in a research note. The analyst sees more revenue per lab with the company's existing global network of customers via menu expansion and intra-customer sales additions.

ShowHide Related Items >><<
SOPH Sophia Genetics
$18.11 /

+0.11 (+0.61%)

08/17/21
Fly Intel: Top five analyst initiations
08/17/21 JPMorgan
Sophia Genetics initiated with Overweight, $23 target at JPMorgan
08/17/21 Morgan Stanley
Morgan Stanley starts Sophia Genetics at Overweight with $24 price target
08/17/21 Cowen
Sophia Genetics initiated with an Outperform at Cowen
  • 23
    Jul
SOPH Sophia Genetics
$18.11 /

+0.11 (+0.61%)

Initiation
Fly Intel: Top five analyst initiations » 09:56
08/17/21
08/17
09:56
08/17/21
09:56
CTKB

Cytek Biosciences

$23.13 /

+0.13 (+0.57%)

, GAMB

Gambling.com

$7.65 /

+0.1 (+1.32%)

, OB

Outbrain

$19.19 /

+ (+0.00%)

, SOPH

Sophia Genetics

$18.15 /

+0.15 (+0.83%)

, CRBU

Caribou Biosciences

$26.70 /

+0.21 (+0.79%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cytek Biosciences (CTKB) initiated with an Overweight at Piper Sandler. 2. Gambling.com (GAMB) initiated with a Buy at Truist, Stifel and Jefferies. 3. Outbrain (OB) initiated with a Buy at Citi, and Needham, initiated with an Outperform at JMP Securities, and Evercore ISI and initiated with a Hold at Jefferies. 4. Sophia Genetics (SOPH) initiated with an Overweight at JPMorgan and an Outperform at Cowen. 5. Caribou Biosciences (CRBU) initiated with a Buy at BofA, a Neutral at Citi and an Outperform at SVB Leerink. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
OB Outbrain
$19.19 /

+ (+0.00%)

CRBU Caribou Biosciences
$26.70 /

+0.21 (+0.79%)

CTKB Cytek Biosciences
$23.13 /

+0.13 (+0.57%)

08/17/21 Morgan Stanley
Cytek Biosciences initiated with an Equal Weight at Morgan Stanley
08/17/21 Goldman Sachs
Cytek Biosciences initiated with a Buy at Goldman Sachs
08/17/21 Piper Sandler
Cytek Biosciences initiated with an Overweight at Piper Sandler
GAMB Gambling.com
$7.65 /

+0.1 (+1.32%)

08/17/21 Truist
Gambling.com initiated with a Buy at Truist
08/17/21 Jefferies
Gambling.com initiated with a Buy at Jefferies
08/17/21 Stifel
Stifel starts Gambling.com at Buy with $10 price target
08/17/21 Stifel
Gambling.com initiated with a Buy at Stifel
OB Outbrain
$19.19 /

+ (+0.00%)

08/17/21 Jefferies
Jefferies starts Outbrain at Hold, favors other digital ad names
08/17/21 Evercore ISI
Evercore ISI starts Outbrain at Outperform with $25 price target
08/17/21 Evercore ISI
Outbrain initiated with an Outperform at Evercore ISI
08/17/21 Jefferies
Outbrain initiated with a Hold at Jefferies
SOPH Sophia Genetics
$18.15 /

+0.15 (+0.83%)

08/17/21 JPMorgan
Sophia Genetics initiated with Overweight, $23 target at JPMorgan
08/17/21 Morgan Stanley
Morgan Stanley starts Sophia Genetics at Overweight with $24 price target
08/17/21 Cowen
Sophia Genetics initiated with an Outperform at Cowen
08/17/21 JPMorgan
Sophia Genetics initiated with an Overweight at JPMorgan
CRBU Caribou Biosciences
$26.70 /

+0.21 (+0.79%)

08/17/21 SVB Leerink
SVB Leerink bullish on Caribou Biosciences, initiates with an Outperform
08/17/21 SVB Leerink
Caribou Biosciences initiated with an Outperform at SVB Leerink
08/17/21 BofA
BofA starts Caribou Biosciences at Buy with $30 price target
08/17/21 BofA
Caribou Biosciences initiated with a Buy at BofA
  • 23
    Jul
  • 23
    Jul
  • 23
    Jul
  • 23
    Jul
  • 23
    Jul
GAMB Gambling.com
$7.65 /

+0.1 (+1.32%)

CTKB Cytek Biosciences
$23.13 /

+0.13 (+0.57%)

Initiation
Sophia Genetics initiated with Overweight, $23 target at JPMorgan » 08:47
08/17/21
08/17
08:47
08/17/21
08:47
SOPH

Sophia Genetics

$18.00 /

-0.06 (-0.33%)

JPMorgan analyst Tycho…

JPMorgan analyst Tycho Peterson initiated coverage of Sophia Genetics with an Overweight rating and $23 price target. As a "first mover with leading scale and accuracy," as well as multiple future expansion opportunities, Sophia is positioned to drive "durable high" revenue growth, and its software-as-a-service model confers significant operating leverage over time, Peterson tells investors in a research note. He believes the stock's current valuation "leaves meaningful upside."

ShowHide Related Items >><<
SOPH Sophia Genetics
$18.00 /

-0.06 (-0.33%)

08/17/21 Morgan Stanley
Morgan Stanley starts Sophia Genetics at Overweight with $24 price target
08/17/21 Cowen
Sophia Genetics initiated with an Outperform at Cowen
08/17/21 JPMorgan
Sophia Genetics initiated with an Overweight at JPMorgan
08/17/21 Morgan Stanley
Sophia Genetics initiated with an Overweight at Morgan Stanley
  • 23
    Jul
SOPH Sophia Genetics
$18.00 /

-0.06 (-0.33%)

Initiation
Morgan Stanley starts Sophia Genetics at Overweight with $24 price target » 07:56
08/17/21
08/17
07:56
08/17/21
07:56
SOPH

Sophia Genetics

$18.00 /

-0.06 (-0.33%)

As previously reported,…

As previously reported, Morgan Stanley analyst Tejas Savant initiated coverage of Sophia Genetics with an Overweight rating and $24 price target. Sophia's "highly differentiated," cloud-based informatics platform is easy to deploy, affordable to access and capable of enabling precision medicine at scale, said Savant, who projects a "robust" top-line compound annual growth rate of about 40% through 2025.

ShowHide Related Items >><<
SOPH Sophia Genetics
$18.00 /

-0.06 (-0.33%)

08/17/21 Cowen
Sophia Genetics initiated with an Outperform at Cowen
08/17/21 JPMorgan
Sophia Genetics initiated with an Overweight at JPMorgan
08/17/21 Morgan Stanley
Sophia Genetics initiated with an Overweight at Morgan Stanley
08/17/21 Credit Suisse
Sophia Genetics initiated with an Outperform at Credit Suisse
  • 23
    Jul
SOPH Sophia Genetics
$18.00 /

-0.06 (-0.33%)

Initiation
Sophia Genetics initiated with an Outperform at Cowen » 06:19
08/17/21
08/17
06:19
08/17/21
06:19
SOPH

Sophia Genetics

$18.00 /

-0.06 (-0.33%)

Cowen analyst Doug…

Cowen analyst Doug Schenkel initiated coverage of Sophia Genetics with an Outperform rating.

ShowHide Related Items >><<
SOPH Sophia Genetics
$18.00 /

-0.06 (-0.33%)

08/17/21 JPMorgan
Sophia Genetics initiated with an Overweight at JPMorgan
08/17/21 Morgan Stanley
Sophia Genetics initiated with an Overweight at Morgan Stanley
08/17/21 Credit Suisse
Sophia Genetics initiated with an Outperform at Credit Suisse
  • 23
    Jul
SOPH Sophia Genetics
$18.00 /

-0.06 (-0.33%)

Initiation
Sophia Genetics initiated with an Overweight at JPMorgan » 06:18
08/17/21
08/17
06:18
08/17/21
06:18
SOPH

Sophia Genetics

$18.00 /

-0.06 (-0.33%)

JPMorgan analyst Tycho…

JPMorgan analyst Tycho Peterson initiated coverage of Sophia Genetics with an Overweight rating and $23 price target.

ShowHide Related Items >><<
SOPH Sophia Genetics
$18.00 /

-0.06 (-0.33%)

08/17/21 Morgan Stanley
Sophia Genetics initiated with an Overweight at Morgan Stanley
08/17/21 Credit Suisse
Sophia Genetics initiated with an Outperform at Credit Suisse
  • 23
    Jul
SOPH Sophia Genetics
$18.00 /

-0.06 (-0.33%)

Initiation
Sophia Genetics initiated with an Overweight at Morgan Stanley » 06:16
08/17/21
08/17
06:16
08/17/21
06:16
SOPH

Sophia Genetics

$18.00 /

-0.06 (-0.33%)

Morgan Stanley analyst…

Morgan Stanley analyst Tejas Savant initiated coverage of Sophia Genetics with an Overweight rating and $24 price target.

ShowHide Related Items >><<
SOPH Sophia Genetics
$18.00 /

-0.06 (-0.33%)

08/17/21 Credit Suisse
Sophia Genetics initiated with an Outperform at Credit Suisse
  • 23
    Jul
SOPH Sophia Genetics
$18.00 /

-0.06 (-0.33%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.